Cargando…

Prevalent peripheral arterial disease and inflammatory burden

BACKGROUND: Strong evidence implicates inflammation in the development of atherosclerotic heart disease but less is known about peripheral arterial disease (PAD). Our objective was to test the hypothesis that a composite index of inflammatory burden is associated with PAD. METHODS: Cross-sectional a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cauley, Jane A., Kassem, Ahmed M., Lane, Nancy E., Thorson, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148838/
https://www.ncbi.nlm.nih.gov/pubmed/27938334
http://dx.doi.org/10.1186/s12877-016-0389-9
_version_ 1782473891672752128
author Cauley, Jane A.
Kassem, Ahmed M.
Lane, Nancy E.
Thorson, Sara
author_facet Cauley, Jane A.
Kassem, Ahmed M.
Lane, Nancy E.
Thorson, Sara
author_sort Cauley, Jane A.
collection PubMed
description BACKGROUND: Strong evidence implicates inflammation in the development of atherosclerotic heart disease but less is known about peripheral arterial disease (PAD). Our objective was to test the hypothesis that a composite index of inflammatory burden is associated with PAD. METHODS: Cross-sectional analysis of a randomly-selected group of 903 community-dwelling men in the MrOS cohort recruited between 2000 and 2002. Using blood samples, we measured seven cytokines and related these levels to prevalent PAD (ankle-brachial index (ABI) <0.9) both individually and as part of an “inflammatory burden score” (a composite sum of the number of pro-inflammatory cytokines in the highest quartile). RESULTS: Overall, 6.75% of men had ABI <0.9. The odds of prevalent PAD were higher in men with the highest quartile (Q4) levels of interleukin-6 multivariable (MV) adjusted (odds ratio (OR) =3.95 (95% CI, 1.4–11.3), tumor necrosis factor alpha OR = 4.44 (95% confidence interval (CI), 1.5–12.8), and C-reactive protein OR = 3.63 (95% CI, 1.4–9.4) compared to men in Q1. The magnitude of the association of these cytokines with PAD was similar to the effect of being 10 years older, OR = 2.41 (95% CI, 1.16–3.7). These significant effects persisted after additional MV adjustment for smoking except for CRP. Men with the highest inflammatory burden score (≥3) had 3.6 (95% CI, 1.5–8.7) increased odds of PAD, p trend = 0.03. After smoking adjustment the linear trend was borderline statistically significant (p trend = 0.10). CONCLUSION: Inflammatory burden is associated with prevalent PAD, an association similar to aging 10 years. The inflammatory effects of smoking contributes to the underlying association between inflammation and PAD.
format Online
Article
Text
id pubmed-5148838
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51488382016-12-15 Prevalent peripheral arterial disease and inflammatory burden Cauley, Jane A. Kassem, Ahmed M. Lane, Nancy E. Thorson, Sara BMC Geriatr Research Article BACKGROUND: Strong evidence implicates inflammation in the development of atherosclerotic heart disease but less is known about peripheral arterial disease (PAD). Our objective was to test the hypothesis that a composite index of inflammatory burden is associated with PAD. METHODS: Cross-sectional analysis of a randomly-selected group of 903 community-dwelling men in the MrOS cohort recruited between 2000 and 2002. Using blood samples, we measured seven cytokines and related these levels to prevalent PAD (ankle-brachial index (ABI) <0.9) both individually and as part of an “inflammatory burden score” (a composite sum of the number of pro-inflammatory cytokines in the highest quartile). RESULTS: Overall, 6.75% of men had ABI <0.9. The odds of prevalent PAD were higher in men with the highest quartile (Q4) levels of interleukin-6 multivariable (MV) adjusted (odds ratio (OR) =3.95 (95% CI, 1.4–11.3), tumor necrosis factor alpha OR = 4.44 (95% confidence interval (CI), 1.5–12.8), and C-reactive protein OR = 3.63 (95% CI, 1.4–9.4) compared to men in Q1. The magnitude of the association of these cytokines with PAD was similar to the effect of being 10 years older, OR = 2.41 (95% CI, 1.16–3.7). These significant effects persisted after additional MV adjustment for smoking except for CRP. Men with the highest inflammatory burden score (≥3) had 3.6 (95% CI, 1.5–8.7) increased odds of PAD, p trend = 0.03. After smoking adjustment the linear trend was borderline statistically significant (p trend = 0.10). CONCLUSION: Inflammatory burden is associated with prevalent PAD, an association similar to aging 10 years. The inflammatory effects of smoking contributes to the underlying association between inflammation and PAD. BioMed Central 2016-12-09 /pmc/articles/PMC5148838/ /pubmed/27938334 http://dx.doi.org/10.1186/s12877-016-0389-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Cauley, Jane A.
Kassem, Ahmed M.
Lane, Nancy E.
Thorson, Sara
Prevalent peripheral arterial disease and inflammatory burden
title Prevalent peripheral arterial disease and inflammatory burden
title_full Prevalent peripheral arterial disease and inflammatory burden
title_fullStr Prevalent peripheral arterial disease and inflammatory burden
title_full_unstemmed Prevalent peripheral arterial disease and inflammatory burden
title_short Prevalent peripheral arterial disease and inflammatory burden
title_sort prevalent peripheral arterial disease and inflammatory burden
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148838/
https://www.ncbi.nlm.nih.gov/pubmed/27938334
http://dx.doi.org/10.1186/s12877-016-0389-9
work_keys_str_mv AT cauleyjanea prevalentperipheralarterialdiseaseandinflammatoryburden
AT kassemahmedm prevalentperipheralarterialdiseaseandinflammatoryburden
AT lanenancye prevalentperipheralarterialdiseaseandinflammatoryburden
AT thorsonsara prevalentperipheralarterialdiseaseandinflammatoryburden
AT prevalentperipheralarterialdiseaseandinflammatoryburden